Výsledky vyhledávání - "Livia Kelemen"

Autor: Francesco Fallo, Michael Stowasser, Livia Kelemen, A. So, Y. Jeske, Richard D. Gordon, Catia Pilon

Publikováno v: High Blood Pressure & Cardiovascular Prevention. 14:75-81

Numerous recent reports suggest that primary aldosteronism (PAL) is much more common than previously thought, accounting for 5–10% of hypertensive patients with most being normokalaemic. A recent Framingham study analysis has revealed the aldostero

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2a525d5108d6fb7509bb45dc2d8afc62
https://doi.org/10.2165/00151642-200714020-00004

Zobrazit plný text záznamu

The AIB1 Polyglutamine Repeat Does Not Modify Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Publikováno v: Cancer Epidemiology, Biomarkers & Prevention. 15:76-79

This is by far the largest study of its kind to date, and further suggests that AIB1 does not play a substantial role in modifying the phenotype of BRCA1 and BRCA2 carriers. The AIB1 gene encodes the AIB1/SRC-3 steroid hormone receptor coactivator, a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35ae312df620050e131bdb32a64f3bf8
https://doi.org/10.1158/1055-9965.epi-05-0709

Zobrazit plný text záznamu

Association Between Apolipoprotein E ɛ4 and Neuropsychiatric Symptoms During Interferon α Treatment for Chronic Hepatitis C

Autor: Claudia Shorthouse, Elizabeth E. Powell, Brian Kelly, David M. Purdie, Nirmala Pandeya, Peter A Gochee, Livia Kelemen, Julie R. Jonsson

Publikováno v: Psychosomatics. 45:49-57

Neuropsychiatric complications are common in patients with chronic hepatitis C undergoing treatment with interferon alpha. These side effects include alterations of mood, cognition, and neuroendocrine function and are unpredictable. In a number of ne

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::605522ec33434b2a4e24d20ab8cf8554
https://doi.org/10.1176/appi.psy.45.1.49

Zobrazit plný text záznamu

Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families

Autor: David L. Duffy, Richard D. Gordon, A. So, Chiara Bertello, Franco Veglio, Y. Jeske, Livia Kelemen, Norlela Sukor, Michael Stowasser, Paolo Mulatero

Publikováno v: Journal of hypertension. 26(8)

Familial hyperaldosteronism type II is a hereditary form of primary aldosteronism not attributable to the hybrid CYP11B1/CYP11B2 mutation that causes glucocorticoid remediable aldosteronism (or familial hyperaldosteronism type I). Although genetic de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20f0673d67720347d8e05705c13bc63e
https://pubmed.ncbi.nlm.nih.gov/18622235

Zobrazit plný text záznamu

Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II

Autor: Richard D. Gordon, A. So, Livia Kelemen, Norlela Sukor, B. Bulmer, C. Willys, Y. Jeske, David L. Duffy, Michael Stowasser

Publikováno v: Clinical and experimental pharmacologyphysiology. 35(4)

1. There are two types of familial hyperaldosteronism (FH): FH-I and FH-II. FH-I is caused by a hybrid CYP11B1/CYP11B2 gene mutation. The genetic cause of FH-II, which is more common, is unknown. Adrenal hyperplasia and adenomas are features. We prev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::135ff6f276455d81d96d477101215060
https://pubmed.ncbi.nlm.nih.gov/18307725

Zobrazit plný text záznamu

No evidence for coding region mutations in the retinoblastoma-associated Kruppel-associated box protein gene (RBaK) causing familial hyperaldosteronism type II

Autor: Y. Jeske, Livia Kelemen, David L. Duffy, Richard D. Gordon, Michael Stowasser, A. So

Publikováno v: Clinical endocrinology. 65(6)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ab701b130613e3d2bcb62147c17366b
https://pubmed.ncbi.nlm.nih.gov/17121540

Zobrazit plný text záznamu

Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer

Autor: Penelope M. Webb, Georgia Chenevix-Trench, Amanda B. Spurdle, Melissa C. Southey, Graham G. Giles, Beth Newman, Livia Kelemen, John L. Hopper, Xiaoqing Chen

Publikováno v: Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 14(2)

Deficiencies in DNA repair have been hypothesized to increase cancer risk and excess cancer incidence is a feature of inherited diseases caused by defects in DNA damage recognition and repair. We investigated, using a case-control design, whether the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::176666f33766d420630b2416451a544e
https://pubmed.ncbi.nlm.nih.gov/15734952

Zobrazit plný text záznamu

BRAF polymorphisms and the risk of ovarian cancer of low malignant potential

Autor: Jenny Chang-Claude, Andrew Berchuck, Michael R. James, Joellen M. Schildkraut, Richard A. DiCioccio, Hoda Anton-Culver, Ian G. Campbell, David Peel, Livia Kelemen, Amanda B. Spurdle, David L. Duffy, Valerie McGurie, Alice S. Whittemore, Georgia Chenevix-Trench

Publikováno v: Kelemen, Livia; James, Michael; Spurdle, Amanda; Campbell, Ian; Chang-Claude, Jenny; Peel, David; et al.(2005). BRAF polymorphisms and the risk of ovarian cancer of low malignant potential.. Gynecologic oncology, 97(3), 807-812. doi: 10.1016/j.ygyno.2005.03.007. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/0pr6h4fx

Objective The object of this study was to test the hypothesis that BRAF is a low-risk susceptibility gene for low malignant potential (LMP) ovarian cancer. A recent study of the relationship between BRAF polymorphisms and malignant melanoma identifie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dcb8b0f3f779d71ce901695952ef3d8
https://pubmed.ncbi.nlm.nih.gov/15904951

Zobrazit plný text záznamu

Polymorphisms associated with circulating sex hormone levels in postmenopausal women

Autor: Alison M. Dunning, Louise Tee, Nicholas E. Day, Mitch Dowsett, Douglas F. Easton, Livia Kelemen, Paul D.P. Pharoah, Saeko Ogata, Bruce A.J. Ponder, Karen L. Novik, Robert Luben, Elizabeth Folkerd, Catherine S. Healey

Publikováno v: Journal of the National Cancer Institute. 96(12)

Polymorphisms associated with circulating sex hormone levels in postmenopausal women Background: Reports suggest a relationship between circulating sex hormone levels and breast cancer risk, but genetic association studies have been inconclusive. We

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16be131b23113b3e5b5eb3e65d2ac1ae
https://pubmed.ncbi.nlm.nih.gov/15657347

Zobrazit plný text záznamu

RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women

Autor: David M. Purdie, Livia Kelemen, Dorota M. Gertig, Georgia Chenevix-Trench, Amanda B. Spurdle

Publikováno v: Cancer letters. 218(2)

The RAD52 gene is involved in the homologous recombination repair pathway and is a plausible candidate ovarian cancer predisposition gene. We undertook a case-control comparison of 508 epithelial ovarian cancer cases (91 low malignant potential and 4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d59ee5792050a8fba72c245b47ed5a56
https://pubmed.ncbi.nlm.nih.gov/15670896

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání